I had to unfollow an account that I used to trust for #COVID19 info. It said the current level of COVID in wastewater is “unprecedented.”
COVID is bad enough without inflating risks. No one will listen to us when COVID risks are high if we say silly things like this when COVID is actually low (in aggregate) in the US.
I get it. COVID risks never disappear, but the accounts addicted to spreading fear rather than knowledge need to be rejected, IMO.
People thinking COVID-19 is harmless now should have a listen to the podcast from Quirks and Quarks
https://www.cbc.ca/radio/quirks/mar-15-the-silent-long-term-effects-of-covid-and-more-1.7483146
EEeeek wear a mask.
Ensitrelvir Prevents #COVID19 Infection as Post Exposure Prophylaxis
> Japan-based Shionogi presented results for its investigational antiviral, ensitrelvir, that demonstrated a 67% reduction in the risk of developing COVID-19 in uninfected individuals treated after exposure, compared to a placebo at day 10
How COVID changed Canadians, their health and the future.
https://www.cbc.ca/news/health/second-opinion-covid-canada-health-1.7484095
This week, #Barbados’s Prime Minister Mia Mottley gave a fiery address to parliament, calling the US stance “unfair and unjustified”.
“We could not get through the pandemic without the Cuban nurses and the Cuban doctors,” she said.
Trinidad and Tobago’s prime minister, Keith Rowley, warned that US interference in #Caribbean healthcare decisions was unacceptable.
Caribbean leaders have hit back at a threat issued by the United States government to cancel visas for anyone working with or supporting Cuban medical facilities, citing allegations of forced labour and claiming these missions “enrich the Cuban regime”.
Cuban medical missions, which provide doctors, nurses and other medical staff as well as medical facilities, are critical to healthcare systems in the Caribbean.
#COVID19 #Africa #diseaseprevention #forwardthinking #preparation
COVID-19: How did Africa defy the odds with fewer deaths? | Context https://www.context.news/socioeconomic-inclusion/covid-19-how-did-africa-defy-the-odds-with-fewer-deaths?utm_source=firefox-newtab-en-us
Second time #CDC has reported estimates for more than two regions at a time since October.
To be clear, national data used for chart above are modeled on regional data collection.
LP.8.1 now estimated at majority in Great Lakes, nearing majority in NY/NJ and Mid-Atlantic.
XEC (incl. XEC.4) still around a quarter share in all three regions.
[For color key, see: https://covid.cdc.gov/covid-data-tracker/#variant-proportions]
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #WearAMask #BetterMasks
A FLuQE wavelet opened September, cresting as KP.3.1.1 / MC wave into November. FDA's second-guess vaccine target, KP.2, dropped out in December. Updated #CDC estimates indicate we've been in a JN.1.11 soup pretty much since then.
No new variants broken out by CDC, as KP.1.1.3 / LP descendant LP.8.1 approaches majority.
No recent GISAID data—as Raj's dashboard hasn't updated in near a month.
❖ #ThisIsOurPolio #Covid #Covid19 #SARS2 #variants #CovidIsNotOver #CovidIsAirborne #dataviz #datavis
![Chart: Estimated U.S. Variant Proportions by Common Name
Sources: Centers for Disease Control, CoV-Lineages, NYITCOM Research, Daniele Focosi, World Health Network, others
[ beadsland on Ko-fi ]
Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC.
Five bar-style tree-charts, for fortnights through March 2–15. Legend of last fortnight, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart.
Essentially all WHO-Vaccine-Target JN.1. JN.1.11 accounts for over three fifths; JN.1.11 + FLiRT for near half.
For fortnight of 1/19–2/1, packed bubble charts fill single-variant tiles, indicating diversification of those variants (per GISAID) that wouldn't otherwise be apparent from CDC's Nowcast.
Legend:
LP.8.1 [purple]:
47% - LP.8.1.1 / NY† & other LP.8.1
JN.1 + FLiRT-KS [browns]:
26% - XEC.2†, XEC.8† & other XEC
2% - XEC.4
2% - XEQ
⅒% - other KS.1
JN.1.11 [greens]:
¾% - KP.3
15% - MC.10.1, MC.28.1, MC.19, MC.1 & other KP.3.1.1 / MC
JN.1 + FLiRT [reds]:
4% - LF.7
3% - LB.1.3.1 / NL
0% - LB.1
JN.1.11 + FLiRT [blues]:
½% - XEK
0% - KP.2.3 & KP.1.1.3 / LP
Other [greys]:
½% - JN.1.16
⅐% - other WHO-Vaccine-Target JN.1
⅒% - Other (not specified)
† Dagger variants are not broken out by CDC, yet represent a significant share of recent GISAID sequences.](https://spaces.hcommons.social/media_attachments/files/114/163/035/799/833/179/original/9a1523ae932eddff.jpg "Chart: Estimated U.S. Variant Proportions by Common Name
Sources: Centers for Disease Control, CoV-Lineages, NYITCOM Research, Daniele Focosi, World Health Network, others
[ beadsland on Ko-fi ]
Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC.
Five bar-style tree-charts, for fortnights through March 2–15. Legend of last fortnight, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart.
Essentially all WHO-Vaccine-Target JN.1. JN.1.11 accounts for over three fifths; JN.1.11 + FLiRT for near half.
For fortnight of 1/19–2/1, packed bubble charts fill single-variant tiles, indicating diversification of those variants (per GISAID) that wouldn't otherwise be apparent from CDC's Nowcast.
Legend:
LP.8.1 [purple]:
47% - LP.8.1.1 / NY† & other LP.8.1
JN.1 + FLiRT-KS [browns]:
26% - XEC.2†, XEC.8† & other XEC
2% - XEC.4
2% - XEQ
⅒% - other KS.1
JN.1.11 [greens]:
¾% - KP.3
15% - MC.10.1, MC.28.1, MC.19, MC.1 & other KP.3.1.1 / MC
JN.1 + FLiRT [reds]:
4% - LF.7
3% - LB.1.3.1 / NL
0% - LB.1
JN.1.11 + FLiRT [blues]:
½% - XEK
0% - KP.2.3 & KP.1.1.3 / LP
Other [greys]:
½% - JN.1.16
⅐% - other WHO-Vaccine-Target JN.1
⅒% - Other (not specified)
† Dagger variants are not broken out by CDC, yet represent a significant share of recent GISAID sequences.")
This week's three-minute update on #COVID19 conditions in the US:
- COVID has declined to low levels nationally
- The South and Midwest are at moderate viral risks
- 14 states are at very high or high viral activity
- Tomorrow is Long COVID Awareness Day, and some pertinent links are provided.
Metro Vancouver wastewater COVID surveillance data was published March 14. The most recent test was March 5. #covid #covid19 #wastewater #vancouver #yvr
Good morning, y'all. 5 years ago today I did the first issue of CoronaBuzz, a daily newsletter for updates about covid. Over the next 2.5 years I indexed and tagged over 13,000 articles about covid-19 and its impacts around the world. I am still updating that dataset though much more slowly than I was.
The collection is part of ResearchBuzz Firehose. I have an article on how to explore, search, and monitor it here: https://researchbuzz.me/2024/03/14/coronabuzz-navigating-an-collection-of-over-13800-covid-related-article-summaries/ . I hope you find it useful.
#MIS-C, eine seltene, aber schwere Entzündung nach #COVID19 bei Kindern, wird durch die Reaktivierung des #EpsteinBarr-Virus ausgelöst.
Das #Virus, das meist unbemerkt im Körper bleibt, kann durch eine gestörte #Immunabwehr erneut aktiv werden.
Forschende der #Charité haben entdeckt, dass der Botenstoff #TGFβ diesen Prozess verstärkt. Eine gezielte Hemmung könnte Behandlungswege für MIS-C und möglicherweise auch für #LongCovid eröffnen.
Did Trump allow 500K Americans to die for political gain?
When data showed COVID killed more Black & Hispanic people, the strategy shifted overnight.
Watch this shocking analysis of how racism may have shaped pandemic policies. https://youtu.be/OPGLXTaQ3K0
How about some promising Covid-vaccine-related news? It's all early on, but it's still nice to see — and maybe buried amidst all the other news.
Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials
https://medicine.washu.edu/news/nasal-covid-19-vaccine-based-on-washu-technology-to-enter-u-s-clinical-trials/
Newly Discovered Antibody Protects Against All COVID-19 Variants
https://news.utexas.edu/2024/09/03/newly-discovered-antibody-protects-against-all-covid-19-variants/
(Of course, who knows what will happen with any vaccine work and/or availability given this administration.)
"The act of forgetting has always been a tool of oppression. We cannot adequately resist that which has been revised, erased, or forgotten by our community members. But few will acknowledge that this is happening with COVID. Just as one may utter that “slavery was back then, get over it”, when we use verbiage like “post-pandemic” we are rendering oppression as a static past event rather than an ever-evolving present that shapes our shared future. This tactic has always been useful to those who wish to profit off of our suffering and the cycle will continue to repeat if we do not acknowledge and act on the truth of our current reality. If we do not reckon with our failures to each other around COVID and do the work to remedy it, are we better than those who try to ban our people’s histories’ from the schools? We aid in the crusade to forget every day when we do not consider the pandemic as both current and deadly."
~V. Copeland
https://forgeorganizing.org/article/reflecting-on-covid-year-5/
Keep those #COVID19 vaccinations up to date!
STUDY: "The adjusted RR (95% CI) for developing persistent PCC compared with unvaccinated individuals was 0.81 (0.59-1.10) for 1 dose, 0.42 (0.35-0.52) for 2 doses, and 0.37 (0.27-0.52) for three doses."
Each dose lowers your risk of #LongCOVID.
https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaf133/8071565?login=false
